AP
REGN icon

Atwood & Palmer’s Regeneron Pharmaceuticals REGN Stock Holding History

Atwood & Palmer’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4M Buy
42,332
+630
+2% +$429K 1.41% 34
2026
Q1 		$32.2M Sell
41,702
-115
-0.3% -$88K 1.82% 24
2025
Q4 		$32.3M Buy
41,817
+386
+0.9% +$262K 1.83% 24
2025
Q3 		$23.3M Sell
41,431
-157
-0.4% -$88.8K 1.37% 32
2025
Q2 		$21.8M Sell
41,588
-386
-0.9% -$215K 1.36% 32
2025
Q1 		$26.6M Sell
41,974
-1,709
-4% -$1.18M 1.85% 22
2024
Q4 		$31.1M Sell
43,683
-117
-0.3% -$98.2K 2.13% 17
2024
Q3 		$46M Sell
43,800
-59
-0.1% -$65.7K 3.13% 3
2024
Q2 		$46.1M Sell
43,859
-79
-0.2% -$76.6K 3.49% 1
2024
Q1 		$42.3M Sell
43,938
-536
-1% -$510K 3.21% 1
2023
Q4 		$39.1M Sell
44,474
-851
-2% -$701K 3.16% 3
2023
Q3 		$37.3M Sell
45,325
-150
-0.3% -$118K 3.27% 1
2023
Q2 		$32.7M Buy
45,475
+3,393
+8% +$2.62M 2.92% 5
2023
Q1 		$34.6M Buy
42,082
+90
+0.2% +$67.9K 3.25% 3
2022
Q4 		$30.3M Buy
41,992
+81
+0.2% +$59.8K 2.74% 7
2022
Q3 		$28.9M Buy
41,911
+429
+1% +$270K 2.86% 7
2022
Q2 		$24.5M Buy
41,482
+431
+1% +$280K 2.39% 11
2022
Q1 		$28.7M Buy
41,051
+295
+0.7% +$187K 2.48% 13
2021
Q4 		$25.7M Buy
40,756
+12,454
+44% +$7.66M 2.15% 17
2021
Q3 		$17.1M Buy
28,302
+126
+0.4% +$78.2K 1.53% 29
2021
Q2 		$15.7M Buy
28,176
+28,026
+18,684% +$14.2M 1.41% 31
2021
Q1 		$71K Buy
150
+50
+50% +$24.3K 0.01% 199
2020
Q4 		$48K Buy
100
+25
+33% +$13.5K 0.01% 213
2020
Q3 		$42K Buy
+75
New +$45.5K 0.01% 204

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Atwood & Palmer's REGN Position: Q2 2026 in Review

Atwood & Palmer increased its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q2 2026, buying an estimated $429K and bringing the position to 42,332 shares worth $26.4M. The position accounts for 1.41% of the portfolio, ranked #34.

Atwood & Palmer first reported a position in REGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $46.1M in Q2 2024. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Atwood & Palmer held 42,332 shares of Regeneron Pharmaceuticals worth $26.4M as of Q2 2026.
  • Atwood & Palmer bought 630 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $429K.
  • Regeneron Pharmaceuticals made up 1.41% of Atwood & Palmer's portfolio in Q2 2026, its #34 holding.
  • Atwood & Palmer first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Atwood & Palmer's Regeneron Pharmaceuticals position peaked at $46.1M in Q2 2024.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.